U.S. Food and Drug Administration (FDA): Available under Emergency Use Authorization (EUA)
SARS CoV-2 Antigen – Detects SARS-CoV-2 Nucleocapsid Antigens
Total (Anti-S) — Detects total antibodies including all isotypes (IgG, IgM, IgA) to the SARS-CoV-2 spike protein
Total (Anti-N) — Detects total antibodies including all isotypes (IgG, IgM, IgA) to the SARS-CoV-2 nucleocapsid protein
IgG (Anti-S) — Detects IgG antibodies to the SARS-CoV-2 spike protein
Quantitative IgG (Anti-S) — Measures an individual’s IgG antibody response over time post-infection to SARS-CoV-2 and provides numerical values correlated to the World Health Organization’s (WHO) standard for Anti-SARS-CoV-2 immunoglobulin
CE Mark
Total (Anti-S) — Detects total antibodies including all isotypes (IgG, IgM, IgA) to the SARS-CoV-2 spike protein and provides a semi-quantitative value
Semi-Quantitative IgG (Anti-S) — Detects IgG antibodies including all isotypes (IgG, IgM, IgA) to the SARS-CoV-2 spike protein and provides a semi-quantitative value
Quantitative IgG (Anti-S) — Measures an individual’s IgG antibody response to SARS-CoV-2 spike protein and provides numerical values correlated to the WHO standard for Anti-SARS-CoV-2 immunoglobulin